MBXIX | PBAIX | MBXIX / PBAIX | |
Total Expense Ratio | 2.03 | 0.82 | 248% |
Annual Report Gross Expense Ratio | 2.03 | 0.82 | 248% |
Fund Existence | 9 years | 32 years | - |
Gain YTD | -2.190 | 3.300 | -66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.03B | 3.04B | 264% |
Annual Yield % from dividends | 1.92 | 0.00 | - |
Returns for 1 year | -0.99 | 8.41 | -12% |
Returns for 3 years | 7.87 | 21.87 | 36% |
Returns for 5 years | 52.64 | 26.71 | 197% |
Returns for 10 years | N/A | 33.36 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 18.99 | N/A | N/A |
Saratoga Health & Biotechnology A | |||
GSMGX | 13.59 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth C | |||
JLCYX | 69.59 | N/A | N/A |
JHancock Fundamental Large Cap Core R2 | |||
BPIRX | 14.18 | N/A | N/A |
Boston Partners Long/Short Rsrch Instl | |||
REQCX | 41.54 | -0.09 | -0.22% |
Russell Sustnbl Aware Eq C |